Shenzhen Haiwen Biotechnology Co., Ltd. is a Manufacture of Raw Steroids Powder , semi-finished oils,Finished Liquid , HGH , Peptides and LOCAL ANESTHETIC DRUGS in China .

Sales & Support
Request A Quote -
Select Language
Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
English
French
German
Italian
Russian
Spanish
Portuguese
Dutch
Greek
Japanese
Korean
Arabic
Hindi
Turkish
Indonesian
Vietnamese
Thai
Bengali
Persian
Polish
HomeProductsAnti Estrogen Steroids

Pharmaceutical Raw Material Raloxifene Hydrochloride Keoxifene 99% Min Anti-estrogen Drug

I have received my products , you packing is do discreet and perfect , it really amazed me .i will order more from you as soon as possible . Tks!

—— Robet--Australia

I have cooperated with you for many times , your product quality is so great , that is why i still buy the products from you . thank you

—— Richard---American

Hi mate, your best price and high purity product is so competitive in my country , this let me make much profit , my customers are really like it .tks

—— Johnson---Canada

I'm Online Chat Now

Pharmaceutical Raw Material Raloxifene Hydrochloride Keoxifene 99% Min Anti-estrogen Drug

Large Image :  Pharmaceutical Raw Material Raloxifene Hydrochloride Keoxifene 99% Min Anti-estrogen Drug

Product Details:

Place of Origin:China
Certification:ISO9001; ISO14000

Payment & Shipping Terms:

Minimum Order Quantity:100g
Price:USD300/100g
Packaging Details:100g/bag, 500g/bag, 1kg/bag
Delivery Time:1-3 work days
Payment Terms:T/T, Western Union, MoneyGram
Supply Ability:100kg/month
Detailed Product Description
CAS:: 82640-04-8 Assay:: 99%

 

Pharmaceutical Raw Material Raloxifene Hydrochloride Keoxifene 99% Min Anti-estrogen Drug

 

Tag:Hormone,Keoxifene,Keoxifene Hydrochloride,Evista

 

Product Name

Raloxifene Hydrochloride

Synonym

Raloxifene HCL,Keoxifene,Keoxifene Hydrochloride,

CAS

82640-04-8

MF

C28H28ClNO4S

MW

510.04

Molecular Structure

Pharmaceutical Raw Material Raloxifene Hydrochloride Keoxifene 99% Min Anti-estrogen Drug

Assay

99%

Quality Standards

USP

Appearance

White crystalline powder

Package

1kg/Foil bag

 

Place of Origin

China

Brand Name

SMQ

Certification

ISO9001, ISO14000, KOSHER

Model Number

82640-04-8

MOQ

10g

Ref. Price

USD 1.17/g

Packaging Details

1kg/bag,100grams/bag, 10grams/bag

Delivery Time

1-3 days

Payment Terms

T/T, Western union, Money gram

Supply Ability

100KGS/week

 

1. OverView:

Evista (Raloxifene Hydrochloride) is an estrogen agonist/antagonist, referred to as a selective estrogen receptor modulator (SERM) and belongs to the benzothiophene class of compounds. The biological actions of Raloxifene are largely mediated through binding to estrogen receptors. This binding results in activation of estrogenic pathways in some tissues (Agonism) and and the blockade of estrogenic pathways in other tissues (Antagonism).

 

2. Why is this medication prescribed:

Raloxifene is used to prevent and treat osteoporosis (condition in which the bones become thin and weak and break easily) in women who have undergone menopause (change of life; end of menstrual periods). Raloxifene is also used to decrease the risk of developing invasive breast cancer (breast cancer that has spread outside of the milk ducts or lobules into the surrounding breast tissue) in women who are at high risk of developing this type of cancer or who have osteoporosis. Raloxifene cannot be used to treat invasive breast cancer or to prevent invasive breast cancer from coming back in women who have already had the condition. Raloxifene also cannot be used to decrease the risk of developing non-invasive breast cancer. Raloxifene is in a class of medications called selective estrogen receptor modulators (SERMs). Raloxifene prevents and treats osteoporosis by mimicking the effects of estrogen (a female hormone produced by the body) to increase the density (thickness) of bone. Raloxifene decreases the risk of developing invasive breast cancer by blocking the effects of estrogen on breast tissue. This may stop the development of tumors that need estrogen to grow.

 

3. Use and Dose:

Evista is specifically approved for the treatment and prevention of osteoporosis in postmenopausal women, the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis and the reduction in risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer. Evista is supplied as a 60 mg tablet designed for oral administration. The recommended initial dose of the drug is one 60 mg tablet daily, which may be administered any time of day without regard to meals.

 

 

 

Our advantages:

1. High quality products with competitive prices.

2. We provide professional service.

3. Enough stock and Fast delivery.

4. We asure safe and effective shipping method.

5. Fast response to any emails or problems.

 

Available tracking numbers to USA:

EE689150169CN

EE689150084CN

EE750056148CN

EE689151059CN

EA211716874HK

 

Contact Details
Shenzhen Haiwen Biotechnology Co.,Ltd

Contact Person: Mrs. Lisa

Send your inquiry directly to us (0 / 3000)

Other Products

Topical Pain Reliever Benzocaine Anti Estrogen Steroids for Local Anesthetics Analgesic

High Purity Raw Powder Tamoxifen Citrate Nolvadex for Anti Estrogen Steroids

Clomiphene Citrate Anti Estrogen Clomid Steroids Musclebuilding Clomifene Citrate

Anti Estrogen Nolvadex Dianabol Powder Anastrozole for Body Supplement CAS 120511-73-1

Raw Anti Estrogen Steroids Sildenafil Citrate for Sex Enhance CAS171599-83-0

Anti Estrogen Tamoxifen citrate Nolvadex Dianabol Powder CAS107868-30-4

Tamoxifen Citrate Anti Estrogen Steroids Nolvadex for Bodybuilding 54965-24-1